Bone Marrow & Stem Cell Transplant | Clinical

Bishop Reviews Risk Assessment and Treatment for GVHD

July 06, 2022

Michael R. Bishop, MD, discussed a patient with graft-versus-host disease who first underwent a myeloablative conditioning regimen and peripheral blood stem-cell matched hematopoietic cell transplant as treatment.